VYNE Logo

VYNE Therapeutics Inc. (VYNE) 

NASDAQ$1.87
Market Cap
$28.44M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
342 of 924
Rank in Industry
201 of 527

VYNE Insider Trading Activity

VYNE Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$43,8001100
Sells
$000

Related Transactions

LEPORE PATRICK Gdirector1$43,8000$0$43,800

About VYNE Therapeutics Inc.

VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is also developing VYN201, a bromodomain and extra-terminal (BET) inhibitor for various â€¦

Insider Activity of VYNE Therapeutics Inc.

Over the last 12 months, insiders at VYNE Therapeutics Inc. have bought $43,800 and sold $0 worth of VYNE Therapeutics Inc. stock.

On average, over the past 5 years, insiders at VYNE Therapeutics Inc. have bought $5.19M and sold $5.32M worth of stock each year.

Highest buying activity among insiders over the last 12 months: LEPORE PATRICK G (director) — $43,800.

The last purchase of 15,000 shares for transaction amount of $43,800 was made by LEPORE PATRICK G (director) on 2025‑01‑15.

List of Insider Buy and Sell Transactions, VYNE Therapeutics Inc.

2025-01-15PurchaseLEPORE PATRICK Gdirector
15,000
0.106%
$2.92$43,800-11.59%
2023-11-15PurchaseLEPORE PATRICK Gdirector
13,000
0.3748%
$3.91$50,778-45.75%
2021-11-30PurchaseLEPORE PATRICK Gdirector
12,500
0.024%
$1.02$12,699-55.58%
2021-08-25PurchaseLEPORE PATRICK Gdirector
12,500
0.0243%
$1.60$20,000-62.27%
2021-08-16SalePERCEPTIVE ADVISORS LLC10 percent owner
250,000
0.4697%
$1.74$435,000-64.78%
2021-08-13SalePERCEPTIVE ADVISORS LLC10 percent owner
250,000
0.4967%
$1.84$460,000-64.61%
2021-08-12SalePERCEPTIVE ADVISORS LLC10 percent owner
338,897
0.7299%
$2.23$755,740-68.34%
2021-05-26PurchaseLEPORE PATRICK Gdirector
12,500
0.0241%
$3.60$44,958-68.32%
2021-05-06SalePERCEPTIVE ADVISORS LLC10 percent owner
1M
2.0052%
$3.67$3.67M-65.17%
2021-03-15PurchaseLEPORE PATRICK Gdirector
12,500
0.0259%
$7.41$92,563-79.34%
2021-01-28PurchasePERCEPTIVE ADVISORS LLC10 percent owner
4.22M
2.2941%
$2.37$10M-69.62%
2020-12-03PurchaseLEPORE PATRICK Gdirector
100,000
0.078%
$1.71$170,850-46.15%
2020-09-08PurchaseDomzalski DavidPresident and CEO
150,000
0.084%
$1.38$207,135+10.54%
2020-09-08PurchaseSaik AndrewChief Financial Officer
80,000
0.0474%
$1.46$116,960+10.54%
2020-06-09PurchasePERCEPTIVE ADVISORS LLC10 percent owner
5.41M
3.4508%
$1.85$10M-19.14%
2018-07-24SalePresidio Partners 2007 GP, L.P.
1M
4.3407%
$7.65$7.65M-11.34%
2018-01-25PurchaseRemeditex Ventures LLC10 percent owner
200,000
0.6735%
$17.00$3.4M-71.72%
2018-01-25PurchasevenBio Global Strategic Fund II L.P.10 percent owner
530,000
1.7848%
$17.00$9.01M-71.72%
2018-01-25PurchaseVivo Capital VIII, LLC10 percent owner
588,236
1.9809%
$17.00$10M-71.72%
2018-01-25PurchaseCha Albertdirector
588,236
1.9809%
$17.00$10M-71.72%
Total: 20
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
LEPORE PATRICK Gdirector
51472
0.3384%
$96,252.6470<0.0001%
PERCEPTIVE ADVISORS LLC10 percent owner
4935057
32.4463%
$9.23M24<0.0001%
Remeditex Ventures LLC10 percent owner
1582854
10.4067%
$2.96M10
Domzalski DavidPresident and CEO
1315966
8.652%
$2.46M10+10.54%
Saik AndrewChief Financial Officer
340000
2.2354%
$635,800.0010+10.54%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$14,315,062
61
-6.21%
$33.06M
$53,490,060
55
19.35%
$30.29M
$94,084,626
29
-21.08%
$24.05M
$1,295,471
17
21.79%
$25.73M
$17,594,514
16
-20.37%
$33.77M

VYNE Institutional Investors: Active Positions

Increased Positions19+55.88%1M+14.41%
Decreased Positions12-35.29%646,991-8.8%
New Positions9New939,171New
Sold Out Positions6Sold Out514,615Sold Out
Total Postitions41+20.59%8M+5.61%

VYNE Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Cormorant Asset Management, Lp$2,580.009.3%1.39M00%2024-12-31
Eventide Asset Management, Llc$2,580.009.3%1.39M00%2024-12-31
Citadel Advisors Llc$2,276.008.2%1.23M+43,044+3.63%2024-12-31
Dsc Advisors, L.P.$1,288.004.64%696,46500%2024-09-30
Vanguard Group Inc$879.003.17%475,129+31,611+7.13%2024-12-31
Acorn Capital Advisors, Llc$845.003.05%456,970+456,970New2024-12-31
Palo Alto Investors Lp$824.002.97%445,43400%2024-12-31
Exome Asset Management Llc$654.002.36%353,43400%2024-12-31
Oconnor, A Distinct Business Unit Of Ubs Asset Management Am$455.001.64%245,800+245,800New2024-12-31
Schonfeld Strategic Advisors Llc$327.001.18%176,658+8,058+4.78%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
1.75SellsBuysStrong BuyBuyHoldSellStrong SellVYNEHighAverageLowSeries 4